echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Multicenter International Study: Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Cerebral Venous Thrombosis

    Stroke: Multicenter International Study: Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Cerebral Venous Thrombosis

    • Last Update: 2022-03-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Recently, a study published in the journal STROKE showed that in patients with intracranial venous thrombosis (CVT), DOAC was similar in efficacy to warfarin, but had a better safety profile


    Recently, a study published in the journal STROKE showed that in patients with intracranial venous thrombosis (CVT), DOAC was similar in efficacy to warfarin, but had a better safety profile


    Results of the study showed that of 1025 patients with CVT at 27 centers, 845 were included in the final analysis


    Table 1.


    Table 1.


    Original source:

    Original source:

    Yaghi S, Shu L, Bakradze E et al.


    Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study

    Leave a Comment
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.